PH regulators in invadosomal functioning: Proton delivery for matrix tasting

European Journal of Cell Biology

Volumn 91, Issue 11-12, 2012, Pages 847-860

  Brisson, Lucie ^a   Reshkin, Stephan J ^b   Goré, Jacques ^a   Roger, Sébastien ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Cancer cells; Cell invasiveness; Extracellular matrix remodeling; Invadopodia; Na+ H+ exchanger; Osteoclasts; PH regulation; Podosomes; Proteases; Vacuolar ATPase

Indexed keywords

ACTIN; ACTIN RELATED PROTEIN 2-3 COMPLEX; ADAM PROTEIN; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE II; CATHEPSIN; CAVEOLIN 1; COFILIN; COLLAGEN TYPE 1; CYSTEINE DERIVATIVE; GELATINASE A; GELATINASE B; GLUCOSE TRANSPORTER; GUANOSINE TRIPHOSPHATASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; PHOSPHOLIPASE C; PROTEIN CDC42; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SERINE PROTEINASE; SODIUM PROTON EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 1; SODIUM PROTON EXCHANGE PROTEIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR NFAT; UNINDEXED DRUG;

ACIDITY; ALBERS SCHOENBERG DISEASE; BONE REMODELING; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL MEMBRANE; CELL PH; CELL STRUCTURE; DEGRADATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INVADOSOME; LEUKOCYTE; METASTASIS; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PODOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SHORT SURVEY; TISSUE REPAIR;

ANIMALS; CELL ADHESION; CELL MEMBRANE STRUCTURES; EXTRACELLULAR MATRIX; HUMANS; HYDROGEN-ION CONCENTRATION; ION TRANSPORT; OSTEOCLASTS; PEPTIDE HYDROLASES; PROTONS;

EID: 84867405330     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2012.04.004     Document Type: Short Survey

References (245)

1. Al-Baldawi N.F., Abercrombie R.F. Cytoplasmic hydrogen ion diffusion coefficient. Biophys. J. 1992, 61:1470-1479.
2. Alexander N.R., Branch K.M., Parekh A., Clark E.S., Iwueke I.C., Guelcher S.A., Weaver A.M. Extracellular matrix rigidity promotes invadopodia activity. Curr. Biol. 2008, 18:1295-1299.
3. Andersen T.L., del Carmen Ovejero M., Kirkegaard T., Lenhard T., Foged N.T., Delaisse J.M. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. Bone 2004, 35:1107-1119.
4. Arnett T.R. Extracellular pH regulates bone cell function. J. Nutr. 2008, 138:415S-418S.
5. Arnett T.R. Acidosis, hypoxia and bone. Arch. Biochem. Biophys. 2010, 503:103-109.
6. Artym V.V., Kindzelskii A.L., Chen W.T., Petty H.R. Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton. Carcinogenesis 2002, 23:1593-1601.
7. Artym V.V., Matsumoto K., Mueller S.C., Yamada K.M. Dynamic membrane remodeling at invadopodia differentiates invadopodia from podosomes. Eur. J. Cell Biol. 2011, 90:172-180.
8. Attanasio F., Caldieri G., Giacchetti G., van Horssen R., Wieringa B., Buccione R. Novel invadopodia components revealed by differential proteomic analysis. Eur. J. Cell Biol. 2011, 90:115-127.
9. Ayala I., Baldassarre M., Caldieri G., Buccione R. Invadopodia: a guided tour. Eur. J. Cell Biol. 2006, 85:159-164.
10. Ayala I., Baldassarre M., Giacchetti G., Caldieri G., Tete S., Luini A., Buccione R. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J. Cell Sci. 2008, 121:369-378.
11. Baldassarre M., Pompeo A., Beznoussenko G., Castaldi C., Cortellino S., McNiven M.A., Luini A., Buccione R. Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol. Biol. Cell 2003, 14:1074-1084.
12. Baron R. Molecular mechanisms of bone resorption by the osteoclast. Anat. Rec. 1989, 224:317-324.
13. Baron R., Neff L., Louvard D., Courtoy P.J. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J. Cell Biol. 1985, 101:2210-2222.
14. Barrett A.J., Kirschke H. Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol. 1981, 80(Pt C):535-561.
15. + ATPase: molecular structure and function, physiological roles and regulation. J. Exp. Biol. 2006, 209:577-589.
16. Bierman A.J., Cragoe E.J., de Laat S.W., Moolenaar W.H. Bicarbonate determines cytoplasmic pH and suppresses mitogen-induced alkalinization in fibroblastic cells. J. Biol. Chem. 1988, 263:15253-15256.
17. Binks M., Jones G.E., Brickell P.M., Kinnon C., Katz D.R., Thrasher A.J. Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome. Eur. J. Immunol. 1998, 28:3259-3267.
18. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., Engler J.A. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 1993, 4:197-250.
19. Biskobing D.M., Fan D. Acid pH increases carbonic anhydrase II and calcitonin receptor mRNA expression in mature osteoclasts. Calcif. Tissue Int. 2000, 67:178-183.
20. Blair H.C., Teitelbaum S.L., Ghiselli R., Gluck S. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 1989, 245:855-857.
21. Bodin P., Burnstock G. Purinergic signalling: ATP release. Neurochem. Res. 2001, 26:959-969.
22. Boron W.F. Intracellular pH regulation in epithelial cells. Annu. Rev. Physiol. 1986, 48:377-388.
23. Boron W.F. Regulation of intracellular pH. Adv. Physiol. Educ. 2004, 28:160-179.
24. + exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J. Biol. Chem. 2004, 279:26991-27007.
25. Bouyer P., Sakai H., Itokawa T., Kawano T., Fulton C.M., Boron W.F., Insogna K.L. Colony-stimulating factor-1 increases osteoclast intracellular pH and promotes survival via the electroneutral Na/HCO3 cotransporter NBCn1. Endocrinology 2007, 148:831-840.
26. Bowden E.T., Onikoyi E., Slack R., Myoui A., Yoneda T., Yamada K.M., Mueller S.C. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp. Cell Res. 2006, 312:1240-1253.
27. Brisson L., Gillet L., Calaghan S., Besson P., Le Guennec J.Y., Roger S., Gore J. Na(V)1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H(+) efflux in caveolae. Oncogene 2011, 30:2070-2076.
28. Brix K., Dunkhorst A., Mayer K., Jordans S. Cysteine cathepsins: cellular roadmap to different functions. Biochimie 2008, 90:194-207.
29. Bromme D., Lecaille F. Cathepsin K inhibitors for osteoporosis and potential off-target effects. Expert Opin. Investig. Drugs 2009, 18:585-600.
30. Buccione R., Orth J.D., McNiven M.A. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat. Rev. Mol. Cell Biol. 2004, 5:647-657.
31. Burgstaller G., Gimona M. Podosome-mediated matrix resorption and cell motility in vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H3001-H3005.
32. Busco G., Cardone R.A., Greco M.R., Bellizzi A., Colella M., Antelmi E., Mancini M.T., Dell'aquila M.E., Casavola V., Paradiso A., Reshkin S.J. NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space. FASEB J. 2010.
33. Caldieri G., Buccione R. Aiming for invadopodia: organizing polarized delivery at sites of invasion. Trends Cell Biol. 2010, 20:64-70.
34. Calle Y., Jones G.E., Jagger C., Fuller K., Blundell M.P., Chow J., Chambers T., Thrasher A.J. WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption. Blood 2004, 103:3552-3561.
35. + exchanger in metastasis. Nat. Rev. Cancer 2005, 5:786-795.
36. Carreno S., Gouze M.E., Schaak S., Emorine L.J., Maridonneau-Parini I. Lack of palmitoylation redirects p59Hck from the plasma membrane to p61Hck-positive lysosomes. J. Biol. Chem. 2000, 275:36223-36229.
37. Casey J.R., Grinstein S., Orlowski J. Sensors and regulators of intracellular pH. Nat. Rev. Mol. Cell Biol. 2010, 11:50-61.
38. Chabadel A., Banon-Rodriguez I., Cluet D., Rudkin B.B., Wehrle-Haller B., Genot E., Jurdic P., Anton I.M., Saltel F. CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclasts. Mol. Biol. Cell 2007, 18:4899-4910.
39. +-ATPase binding to microfilaments: regulation in response to phosphatidylinositol 3-kinase activity and detailed characterization of the actin-binding site in subunit B. J. Biol. Chem. 2004, 279:7988-7998.
40. Chen W.T. Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J. Exp. Zool. 1989, 251:167-185.
41. + exchanger NHE1 by post-translational regulation that is important for cervical cancer cell invasiveness. J. Cell. Physiol. 2008, 214:810-819.
42. Chiche J., Fur Y.L., Vilmen C., Frassineti F., Daniel L., Halestrap A.P., Cozzone P.J., Pouyssegur J., Lutz N.W. In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH. Int. J. Cancer 2012, 130:1511-1520.
43. Chiche J., Ilc K., Laferriere J., Trottier E., Dayan F., Mazure N.M., Brahimi-Horn M.C., Pouyssegur J. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 2009, 69:358-368.
44. Clark E.S., Weaver A.M. A new role for cortactin in invadopodia: regulation of protease secretion. Eur. J. Cell Biol. 2008, 87:581-590.
45. Clark E.S., Whigham A.S., Yarbrough W.G., Weaver A.M. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 2007, 67:4227-4235.
46. Collin O., Tracqui P., Stephanou A., Usson Y., Clement-Lacroix J., Planus E. Spatiotemporal dynamics of actin-rich adhesion microdomains: influence of substrate flexibility. J. Cell Sci. 2006, 119:1914-1925.
47. Coopman P.J., Do M.T., Thompson E.W., Mueller S.C. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin. Cancer Res. 1998, 4:507-515.
48. Cordat E., Casey J.R. Bicarbonate transport in cell physiology and disease. Biochem. J. 2009, 417:423-439.
49. Cougoule C., Carreno S., Castandet J., Labrousse A., Astarie-Dequeker C., Poincloux R., Le Cabec V., Maridonneau-Parini I. Activation of the lysosome-associated p61Hck isoform triggers the biogenesis of podosomes. Traffic 2005, 6:682-694.
50. Coussens L.M., Fingleton B., Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002, 295:2387-2392.
51. Czupalla C., Mansukoski H., Riedl T., Thiel D., Krause E., Hoflack B. Proteomic analysis of lysosomal acid hydrolases secreted by osteoclasts: implications for lytic enzyme transport and bone metabolism. Mol. Cell. Proteomics 2006, 5:134-143.
52. Dalet-Fumeron V., Guinec N., Pagano M. In vitro activation of pro-cathepsin B by three serine proteinases: leucocyte elastase, cathepsin G, and the urokinase-type plasminogen activator. FEBS Lett. 1993, 332:251-254.
53. David-Pfeuty T., Singer S.J. Altered distributions of the cytoskeletal proteins vinculin and alpha-actinin in cultured fibroblasts transformed by Rous sarcoma virus. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:6687-6691.
54. De Milito A., Canese R., Marino M.L., Borghi M., Iero M., Villa A., Venturi G., Lozupone F., Iessi E., Logozzi M., Della Mina P., Santinami M., Rodolfo M., Podo F., Rivoltini L., Fais S. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int. J. Cancer 2010, 127:207-219.
55. Delaisse J.M., Engsig M.T., Everts V., del Carmen Ovejero M., Ferreras M., Lund L., Vu T.H., Werb Z., Winding B., Lochter A., Karsdal M.A., Troen T., Kirkegaard T., Lenhard T., Heegaard A.M., Neff L., Baron R., Foged N.T. Proteinases in bone resorption: obvious and less obvious roles. Clin. Chim. Acta 2000, 291:223-234.
56. Denker S.P., Barber D.L. Cell migration requires both ion translocation and cytoskeletal anchoring by the Na-H exchanger NHE1. J. Cell Biol. 2002, 159:1087-1096.
57. Denker S.P., Huang D.C., Orlowski J., Furthmayr H., Barber D.L. Direct binding of the Na-H exchanger NHE1 to ERM proteins regulates the cortical cytoskeleton and cell shape independently of H(+) translocation. Mol. Cell 2000, 6:1425-1436.
58. Deryugina E.I., Ratnikov B., Monosov E., Postnova T.I., DiScipio R., Smith J.W., Strongin A.Y. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp. Cell Res. 2001, 263:209-223.
59. Desmarais V., Yamaguchi H., Oser M., Soon L., Mouneimne G., Sarmiento C., Eddy R., Condeelis J. N-WASP and cortactin are involved in invadopodium-dependent chemotaxis to EGF in breast tumor cells. Cell Motil. Cytoskeleton 2009, 66:303-316.
60. Destaing O., Saltel F., Geminard J.C., Jurdic P., Bard F. Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol. Biol. Cell 2003, 14:407-416.
61. Dietl K., Renner K., Dettmer K., Timischl B., Eberhart K., Dorn C., Hellerbrand C., Kastenberger M., Kunz-Schughart L.A., Oefner P.J., Andreesen R., Gottfried E., Kreutz M.P. Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J. Immunol. 2010, 184:1200-1209.
62. Ebbesen P., Pettersen E.O., Gorr T.A., Jobst G., Williams K., Kieninger J., Wenger R.H., Pastorekova S., Dubois L., Lambin P., Wouters B.G., Van Den Beucken T., Supuran C.T., Poellinger L., Ratcliffe P., Kanopka A., Gorlach A., Gasmann M., Harris A.L., Maxwell P., Scozzafava A. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies. J. Enzyme Inhib. Med. Chem. 2009, 24(Suppl. 1):1-39.
63. +-ATPases as a new strategy against cancer. Cancer Res. 2007, 67:10627-10630.
64. Fang J.S., Gillies R.D., Gatenby R.A. Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin. Cancer Biol. 2008, 18:330-337.
65. Farina C., Gagliardi S. Selective inhibition of osteoclast vacuolar H(+)-ATPase. Curr. Pharm. Des. 2002, 8:2033-2048.
66. Forgac M. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol. 2007, 8:917-929.
67. Frantz C., Barreiro G., Dominguez L., Chen X., Eddy R., Condeelis J., Kelly M.J., Jacobson M.P., Barber D.L. Cofilin is a pH sensor for actin free barbed end formation: role of phosphoinositide binding. J. Cell Biol. 2008, 183:865-879.
68. + efflux by the Na-H exchanger NHE1 for polarity of migrating cells. J. Cell Biol. 2007, 179:403-410.
69. Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147:992-1009.
70. Gallagher F.A., Kettunen M.I., Day S.E., Hu D.E., Ardenkjaer-Larsen J.H., Zandt R., Jensen P.R., Karlsson M., Golman K., Lerche M.H., Brindle K.M. Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate. Nature 2008, 453:940-943.
71. Gambhir S.S. Molecular imaging of cancer with positron emission tomography. Nat. Rev. Cancer 2002, 2:683-693.
72. Gatenby R.A., Gawlinski E.T., Gmitro A.F., Kaylor B., Gillies R.J. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 2006, 66:5216-5223.
73. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 2004, 4:891-899.
74. Gay C.V., Mueller W.J. Carbonic anhydrase and osteoclasts: localization by labeled inhibitor autoradiography. Science 1974, 183:432-434.
75. Ghersi G., Zhao Q., Salamone M., Yeh Y., Zucker S., Chen W.T. The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices. Cancer Res. 2006, 66:4652-4661.
76. Gillet L., Roger S., Besson P., Lecaille F., Gore J., Bougnoux P., Lalmanach G., Le Guennec J.Y. Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells. J. Biol. Chem. 2009, 284:8680-8691.
77. Gillies R.J., Raghunand N., Karczmar G.S., Bhujwalla Z.M. MRI of the tumor microenvironment. J. Magn. Reson. Imaging 2002, 16:430-450.
78. Glunde K., Guggino S.E., Solaiyappan M., Pathak A.P., Ichikawa Y., Bhujwalla Z.M. Extracellular acidification alters lysosomal trafficking in human breast cancer cells. Neoplasia 2003, 5:533-545.
79. Gonda T., Maouyo D., Rees S.E., Montrose M.H. Regulation of intracellular pH gradients by identified Na/H exchanger isoforms and a short-chain fatty acid. Am. J. Physiol. 1999, 276:G259-G270.
80. Grey M.J., Tang Y., Alexov E., McKnight C.J., Raleigh D.P., Palmer A.G. Characterizing a partially folded intermediate of the villin headpiece domain under non-denaturing conditions: contribution of His41 to the pH-dependent stability of the N-terminal subdomain. J. Mol. Biol. 2006, 355:1078-1094.
81. Guo M., Mathieu P.A., Linebaugh B., Sloane B.F., Reiners J.J. Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B. J. Biol. Chem. 2002, 277:14829-14837.
82. Gupta A., Edwards J.C., Hruska K.A. Cellular distribution and regulation of NHE-1 isoform of the NA-H exchanger in the avian osteoclast. Bone 1996, 18:87-95.
83. Hall T.J., Chambers T.J. Optimal bone resorption by isolated rat osteoclasts requires chloride/bicarbonate exchange. Calcif. Tissue Int. 1989, 45:378-380.
84. + antiporter is the primary proton transport system used by osteoclasts during bone resorption. J. Cell. Physiol. 1990, 142:420-424.
85. +/H(+)-antiporter activity is essential for the induction, but not the maintenance of osteoclastic bone resorption and cytoplasmic spreading. Biochem. Biophys. Res. Commun. 1992, 188:1097-1103.
86. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
87. Harguindey S., Arranz J.L., Wahl M.L., Orive G., Reshkin S.J. Proton transport inhibitors as potentially selective anticancer drugs. Anticancer Res. 2009, 29:2127-2136.
88. Hawkins R.A., Phelps M.E. PET in clinical oncology. Cancer Metastasis Rev. 1988, 7:119-142.
89. Henriksen K., Sorensen M.G., Jensen V.K., Dziegiel M.H., Nosjean O., Karsdal M.A. Ion transporters involved in acidification of the resorption lacuna in osteoclasts. Calcif. Tissue Int. 2008, 83:230-242.
90. Heuser J. Changes in lysosome shape and distribution correlated with changes in cytoplasmic pH. J. Cell Biol. 1989, 108:855-864.
91. Hinton A., Bond S., Forgac M. V-ATPase functions in normal and disease processes. Pflugers Arch. 2009, 457:589-598.
92. +-ATPase contains a filamentous actin binding site. J. Biol. Chem. 2000, 275:32331-32337.
93. Huber V., De Milito A., Harguindey S., Reshkin S.J., Wahl M.L., Rauch C., Chiesi A., Pouyssegur J., Gatenby R.A., Rivoltini L., Fais S. Proton dynamics in cancer. J. Transl. Med. 2010, 8:57.
94. Idris A.I., Landao-Bassonga E., Ralston S.H. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo. Bone 2010, 46:1089-1099.
95. Jahr H., van Driel M., van Osch G.J., Weinans H., van Leeuwen J.P. Identification of acid-sensing ion channels in bone. Biochem. Biophys. Res. Commun. 2005, 337:349-354.
96. Jelassi B., Chantome A., Alcaraz-Perez F., Baroja-Mazo A., Cayuela M.L., Pelegrin P., Surprenant A., Roger S. P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness. Oncogene 2011, 30:2108-2122.
97. 3-exchanger Ae2 results in osteopetrosis in mice. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:1638-1641.
98. Jurdic P., Saltel F., Chabadel A., Destaing O. Podosome and sealing zone: specificity of the osteoclast model. Eur. J. Cell Biol. 2006, 85:195-202.
99. Kajiya H., Okamoto F., Fukushima H., Okabe K. Calcitonin inhibits proton extrusion in resorbing rat osteoclasts via protein kinase A. Pflugers Arch. 2003, 445:651-658.
100. Kato Y., Lambert C.A., Colige A.C., Mineur P., Noel A., Frankenne F., Foidart J.M., Baba M., Hata R., Miyazaki K., Tsukuda M. Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling. J. Biol. Chem. 2005, 280:10938-10944.
101. Kelly T., Mueller S.C., Yeh Y., Chen W.T. Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins. J. Cell. Physiol. 1994, 158:299-308.
102. Kindzelskii A.L., Amhad I., Keller D., Zhou M.J., Haugland R.P., Garni-Wagner B.A., Gyetko M.R., Todd R.F., Petty H.R. Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator. Histochem. Cell Biol. 2004, 121:299-310.
103. Kirschke H., Wiederanders B., Bromme D., Rinne A. Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. Biochem. J. 1989, 264:467-473.
104. Klein M., Seeger P., Schuricht B., Alper S.L., Schwab A. Polarization of Na(+)/H(+) and Cl(-)/HCO (3)(-) exchangers in migrating renal epithelial cells. J. Gen. Physiol. 2000, 115:599-608.
105. Koivusalo M., Welch C., Hayashi H., Scott C.C., Kim M., Alexander T., Touret N., Hahn K.M., Grinstein S. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J. Cell Biol. 2010, 188:547-563.
106. Komarova S.V., Pereverzev A., Shum J.W., Sims S.M., Dixon S.J. Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:2643-2648.
107. Kornak U., Kasper D., Bosl M.R., Kaiser E., Schweizer M., Schulz A., Friedrich W., Delling G., Jentsch T.J. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001, 104:205-215.
108. Kornak U., Schulz A., Friedrich W., Uhlhaas S., Kremens B., Voit T., Hasan C., Bode U., Jentsch T.J., Kubisch C. Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum. Mol. Genet. 2000, 9:2059-2063.
109. Kostoulas G., Lang A., Nagase H., Baici A. Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases. FEBS Lett. 1999, 455:286-290.
110. Kraus M., Wolf B. Implications of acidic tumor microenvironment for neoplastic growth and cancer treatment: a computer analysis. Tumour Biol. 1996, 17:133-154.
111. Kroemer G., Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell. 2008, 13:472-482.
112. Kuwata F., Suzuki N., Otsuka K., Taguchi M., Sasai Y., Wakino H., Ito M., Ebihara S., Suzuki K. Enzymatic regulation of glycolysis and gluconeogenesis in rabbit periodontal ligament under various physiological pH conditions. J. Nihon Univ. Sch. Dent. 1991, 33:81-90.
113. Lagadic-Gossmann D., Huc L., Lecureur V. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ. 2004, 11:953-961.
114. Lagana A., Vadnais J., Le P.U., Nguyen T.N., Laprade R., Nabi I.R., Noel J. Regulation of the formation of tumor cell pseudopodia by the Na(+)/H(+) exchanger NHE1. J. Cell Sci. 2000, 113(Pt 20):3649-3662.
115. Laitala T., Vaananen H.K. Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase. J. Clin. Invest. 1994, 93:2311-2318.
116. Laitala T., Vaananen K. Proton channel part of vacuolar H(+)-ATPase and carbonic anhydrase II expression is stimulated in resorbing osteoclasts. J. Bone Miner. Res. 1993, 8:119-126.
117. Lakkakorpi P.T., Helfrich M.H., Horton M.A., Vaananen H.K. Spatial organization of microfilaments and vitronectin receptor, alpha v beta 3, in osteoclasts. A study using confocal laser scanning microscopy. J. Cell Sci. 1993, 104(Pt 3):663-670.
118. Lakkakorpi P.T., Vaananen H.K. Cytoskeletal changes in osteoclasts during the resorption cycle. Microsc. Res. Tech. 1996, 33:171-181.
119. + exchanger 1 (NHE1): functional and clinical implications. J. Biol. Chem. 2007, 282:37854-37863.
120. Lecaille F., Bromme D., Lalmanach G. Biochemical properties and regulation of cathepsin K activity. Biochimie 2008, 90:208-226.
121. Lecaille F., Kaleta J., Bromme D. Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem. Rev. 2002, 102:4459-4488.
122. Lee B.S., Gluck S.L., Holliday L.S. Interaction between vacuolar H(+)-ATPase and microfilaments during osteoclast activation. J. Biol. Chem. 1999, 274:29164-29171.
123. + exchanger family, regulates osteoclast differentiation and survival. Biochem. Biophys. Res. Commun. 2008, 369:320-326.
124. Lees R.L., Sabharwal V.K., Heersche J.N. Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films. Bone 2001, 28:187-194.
125. Lehenkari P.P., Laitala-Leinonen T., Linna T.J., Vaananen H.K. The regulation of pHi in osteoclasts is dependent on the culture substrate and on the stage of the resorption cycle. Biochem. Biophys. Res. Commun. 1997, 235:838-844.
126. Li Y.P., Chen W., Liang Y., Li E., Stashenko P. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat. Genet. 1999, 23:447-451.
127. Liaudet-Coopman E., Beaujouin M., Derocq D., Garcia M., Glondu-Lassis M., Laurent-Matha V., Prebois C., Rochefort H., Vignon F. Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett. 2006, 237:167-179.
128. Lin H.M., Nakamura H., Noda T., Ozawa H. Localization of H(+)-ATPase and carbonic anhydrase II in ameloblasts at maturation. Calcif. Tissue Int. 1994, 55:38-45.
129. Lin Y., Chang G., Wang J., Jin W., Wang L., Li H., Ma L., Li Q., Pang T. NHE1 mediates MDA-MB-231 cells invasion through the regulation of MT1-MMP. Exp. Cell Res. 2011, 317:2031-2040.
130. Lin Y., Wang J., Jin W., Wang L., Li H., Ma L., Li Q., Pang T. NHE1 mediates migration and invasion of HeLa cells via regulating the expression and localization of MT1-MMP. Cell Biochem. Funct. 2011.
131. Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol. 2007, 17:107-117.
132. Linder S. Invadosomes at a glance. J. Cell Sci. 2009, 122:3009-3013.
133. Linder S., Nelson D., Weiss M., Aepfelbacher M. Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:9648-9653.
134. Linder S., Wiesner C., Himmel M. Degrading devices: invadosomes in proteolytic cell invasion. Annu. Rev. Cell Dev. Biol. 2011, 27:185-211.
135. Lopez-Castejon G., Theaker J., Pelegrin P., Clifton A.D., Braddock M., Surprenant A. P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases. J. Immunol. 2010, 185:2611-2619.
136. Lucien F., Brochu-Gaudreau K., Arsenault D., Harper K., Dubois C.M. Hypoxia-induced invadopodia formation involves activation of NHE-1 by the p90 ribosomal S6 kinase (p90RSK). PLoS One 2011, 6:e28851.
137. Ludwig M.G., Vanek M., Guerini D., Gasser J.A., Jones C.E., Junker U., Hofstetter H., Wolf R.M., Seuwen K. Proton-sensing G-protein-coupled receptors. Nature 2003, 425:93-98.
138. Luxenburg C., Geblinger D., Klein E., Anderson K., Hanein D., Geiger B., Addadi L. The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly. PLoS One 2007, 2:e179.
139. Macheda M.L., Rogers S., Best J.D. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell. Physiol. 2005, 202:654-662.
140. Madshus I.H. Regulation of intracellular pH in eukaryotic cells. Biochem. J. 1988, 250:1-8.
141. Magalhaes M.A., Larson D.R., Mader C.C., Bravo-Cordero J.J., Gil-Henn H., Oser M., Chen X., Koleske A.J., Condeelis J. Cortactin phosphorylation regulates cell invasion through a pH-dependent pathway. J. Cell Biol. 2011, 195:903-920.
142. + exchanger. Can. J. Physiol. Pharmacol. 2006, 84:1081-1095.
143. Martin C., Pedersen S.F., Schwab A., Stock C. Intracellular pH gradients in migrating cells. Am. J. Physiol. Cell Physiol. 2011, 300:C490-C495.
144. Martinez-Zaguilan R., Seftor E.A., Seftor R.E., Chu Y.W., Gillies R.J., Hendrix M.J. Acidic pH enhances the invasive behavior of human melanoma cells. Clin. Exp. Metastasis 1996, 14:176-186.
145. Mattsson J.P., Schlesinger P.H., Keeling D.J., Teitelbaum S.L., Stone D.K., Xie X.S. Isolation and reconstitution of a vacuolar-type proton pump of osteoclast membranes. J. Biol. Chem. 1994, 269:24979-24982.
146. +-ATPase B-subunit using isoform-specific antibodies. J. Bone Miner. Res. 1997, 12:753-760.
147. McLean L.A., Roscoe J., Jorgensen N.K., Gorin F.A., Cala P.M. Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes. Am. J. Physiol. Cell Physiol. 2000, 278:C676-C688.
148. Messier J.M., Shaw L.M., Chafel M., Matsudaira P., Mercurio A.M. Fimbrin localized to an insoluble cytoskeletal fraction is constitutively phosphorylated on its headpiece domain in adherent macrophages. Cell Motil. Cytoskeleton 1993, 25:223-233.
149. Mohamed M.M., Sloane B.F. Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 2006, 6:764-775.
150. Monsky W.L., Chen W.T. Proteases of cell adhesion proteins in cancer. Semin. Cancer Biol. 1993, 4:251-258.
151. Monsky W.L., Lin C.Y., Aoyama A., Kelly T., Akiyama S.K., Mueller S.C., Chen W.T. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res. 1994, 54:5702-5710.
152. Moreau V., Tatin F., Varon C., Genot E. Actin can reorganize into podosomes in aortic endothelial cells, a process controlled by Cdc42 and RhoA. Mol. Cell. Biol. 2003, 23:6809-6822.
153. Mueller S.C., Chen W.T. Cellular invasion into matrix beads: localization of beta 1 integrins and fibronectin to the invadopodia. J. Cell Sci. 1991, 99(Pt 2):213-225.
154. Murphy D.A., Courtneidge S.A. The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat. Rev. Mol. Cell Biol. 2011, 12:413-426.
155. Muzylak M., Arnett T.R., Price J.S., Horton M.A. The in vitro effect of pH on osteoclasts and bone resorption in the cat: implications for the pathogenesis of FORL. J. Cell. Physiol. 2007, 213:144-150.
156. Nakamura I., Pilkington M.F., Lakkakorpi P.T., Lipfert L., Sims S.M., Dixon S.J., Rodan G.A., Duong L.T. Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone. J. Cell Sci. 1999, 112(Pt 22):3985-3993.
157. Neri D., Supuran C.T. Interfering with pH regulation in tumours as a therapeutic strategy. Nat. Rev. Drug Discov. 2011, 10:767-777.
158. Nguyen T.N., Wang H.J., Zalzal S., Nanci A., Nabi I.R. Purification and characterization of beta-actin-rich tumor cell pseudopodia: role of glycolysis. Exp. Cell Res. 2000, 258(1):171-183.
159. Nordstrom T., Rotstein O.D., Romanek R., Asotra S., Heersche J.N., Manolson M.F., Brisseau G.F., Grinstein S. Regulation of cytoplasmic pH in osteoclasts. Contribution of proton pumps and a proton-selective conductance. J. Biol. Chem. 1995, 270:2203-2212.
160. + ATPase activity in osteoclasts. J. Biol. Chem. 1997, 272:6354-6360.
161. Oreffo R.O., Teti A., Triffitt J.T., Francis M.J., Carano A., Zallone A.Z. Effect of vitamin A on bone resorption: evidence for direct stimulation of isolated chicken osteoclasts by retinol and retinoic acid. J. Bone Miner. Res. 1988, 3:203-210.
162. + exchangers of mammalian cells. J. Biol. Chem. 1997, 272:22373-22376.
163. Orlowski J., Grinstein S. Diversity of the mammalian sodium/proton exchanger SLC9 gene family. Pflugers Arch. 2004, 447:549-565.
164. Oser M., Mader C.C., Gil-Henn H., Magalhaes M., Bravo-Cordero J.J., Koleske A.J., Condeelis J. Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia. J. Cell Sci. 2010, 123:3662-3673.
165. Oser M., Yamaguchi H., Mader C.C., Bravo-Cordero J.J., Arias M., Chen X., Desmarais V., van Rheenen J., Koleske A.J., Condeelis J. Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J. Cell Biol. 2009, 186:571-587.
166. Osiak A.E., Zenner G., Linder S. Subconfluent endothelial cells form podosomes downstream of cytokine and RhoGTPase signaling. Exp. Cell Res. 2005, 307:342-353.
167. Palermo C., Joyce J.A. Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol. Sci. 2008, 29:22-28.
168. + exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells. Breast Cancer Res. 2004, 6:R616-R628.
169. Parekh A., Ruppender N.S., Branch K.M., Sewell-Loftin M.K., Lin J., Boyer P.D., Candiello J.E., Merryman W.D., Guelcher S.A., Weaver A.M. Sensing and modulation of invadopodia across a wide range of rigidities. Biophys. J. 2011, 100:573-582.
170. Pastorekova S., Parkkila S., Pastorek J., Supuran C.T. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J. Enzyme Inhib. Med. Chem. 2004, 19:199-229.
171. Patel H., Barber D.L. A developmentally regulated Na-H exchanger in Dictyostelium discoideum is necessary for cell polarity during chemotaxis. J. Cell Biol. 2005, 169:321-329.
172. Peak M., Al-Habori M., Agius L. Regulation of glycogen synthesis and glycolysis by insulin, pH and cell volume. Interactions between swelling and alkalinization in mediating the effects of insulin. Biochem. J. 1992, 282(Pt 3):797-805.
173. Poincloux R., Lizarraga F., Chavrier P. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J. Cell Sci. 2009, 122:3015-3024.
174. Poincloux R., Vincent C., Labrousse A., Castandet J., Rigo M., Cougoule C., Bordier C., Le Cabec V., Maridonneau-Parini I. Re-arrangements of podosome structures are observed when Hck is activated in myeloid cells. Eur. J. Cell Biol. 2006, 85:327-332.
175. Pope B.J., Zierler-Gould K.M., Kuhne R., Weeds A.G., Ball L.J. Solution structure of human cofilin: actin binding, pH sensitivity, and relationship to actin-depolymerizing factor. J. Biol. Chem. 2004, 279:4840-4848.
176. Pouyssegur J., Dayan F., Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441:437-443.
177. Pouyssegur J., Franchi A., L'Allemain G., Paris S. Cytoplasmic pH, a key determinant of growth factor-induced DNA synthesis in quiescent fibroblasts. FEBS Lett. 1985, 190:115-119.
178. Putney L.K., Barber D.L. Expression profile of genes regulated by activity of the Na-H exchanger NHE1. BMC Genomics 2004, 5:46.
179. + exchanger, NHE1: structure, regulation, and cellular actions. Annu. Rev. Pharmacol. Toxicol. 2002, 42:527-552.
180. Ra H.J., Parks W.C. Control of matrix metalloproteinase catalytic activity. Matrix Biol. 2007, 26:587-596.
181. Reshkin S.J., Bellizzi A., Albarani V., Guerra L., Tommasino M., Paradiso A., Casavola V. Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na(+)/H(+) exchange, motility, and invasion induced by serum deprivation. J. Biol. Chem. 2000, 275:5361-5369.
182. + exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J. 2000, 14:2185-2197.
183. Riihonen R., Nielsen S., Vaananen H.K., Laitala-Leinonen T., Kwon T.H. Degradation of hydroxyapatite in vivo and in vitro requires osteoclastic sodium-bicarbonate co-transporter NBCn1. Matrix Biol. 2010, 29:287-294.
184. Riihonen R., Supuran C.T., Parkkila S., Pastorekova S., Vaananen H.K., Laitala-Leinonen T. Membrane-bound carbonic anhydrases in osteoclasts. Bone 2007, 40:1021-1031.
185. Robey I.F., Baggett B.K., Kirkpatrick N.D., Roe D.J., Dosescu J., Sloane B.F., Hashim A.I., Morse D.L., Raghunand N., Gatenby R.A., Gillies R.J. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res. 2009, 69:2260-2268.
186. Rofstad E.K., Mathiesen B., Kindem K., Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 2006, 66:6699-6707.
187. Rossi F., Siniscalco D., Luongo L., De Petrocellis L., Bellini G., Petrosino S., Torella M., Santoro C., Nobili B., Perrotta S., Di Marzo V., Maione S. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone 2009, 44:476-484.
188. Rousselle A.V., Heymann D. Osteoclastic acidification pathways during bone resorption. Bone 2002, 30:533-540.
189. Rozhin J., Sameni M., Ziegler G., Sloane B.F. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res. 1994, 54:6517-6525.
190. Sakurai-Yageta M., Recchi C., Le Dez G., Sibarita J.B., Daviet L., Camonis J., D'Souza-Schorey C., Chavrier P. The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA. J. Cell Biol. 2008, 181:985-998.
191. Saltel F., Daubon T., Juin A., Ganuza I.E., Veillat V., Genot E. Invadosomes: intriguing structures with promise. Eur. J. Cell Biol. 2011, 90:100-107.
192. Saltel F., Destaing O., Bard F., Eichert D., Jurdic P. Apatite-mediated actin dynamics in resorbing osteoclasts. Mol. Biol. Cell 2004, 15:5231-5241.
193. Sapadin A.N., Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J. Am. Acad. Dermatol. 2006, 54:258-265.
194. + antiporter. Cell 1989, 56:271-280.
195. + exchanger-1. Am. J. Physiol. Renal Physiol. 2008, 295:F625-F632.
196. Schlesinger P.H., Mattsson J.P., Blair H.C. Osteoclastic acid transport: mechanism and implications for physiological and pharmacological regulation. Miner. Electrolyte Metab. 1994, 20:31-39.
197. Schoumacher M., Louvard D., Vignjevic D. Cytoskeleton networks in basement membrane transmigration. Eur. J. Cell Biol. 2011, 90:93-99.
198. Scimeca J.C., Franchi A., Trojani C., Parrinello H., Grosgeorge J., Robert C., Jaillon O., Poirier C., Gaudray P., Carle G.F. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 2000, 26:207-213.
199. +-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am. J. Physiol. Cell Physiol. 2004, 286:C1443-C1452.
200. Shattil S.J., Kim C., Ginsberg M.H. The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol. 2010, 11:288-300.
201. Spitzer K.W., Ershler P.R., Skolnick R.L., Vaughan-Jones R.D. Generation of intracellular pH gradients in single cardiac myocytes with a microperfusion system. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H1371-H1382.
202. Spitzer K.W., Skolnick R.L., Peercy B.E., Keener J.P., Vaughan-Jones R.D. Facilitation of intracellular H(+) ion mobility by CO(2)/HCO(3)(-) in rabbit ventricular myocytes is regulated by carbonic anhydrase. J. Physiol. 2002, 541:159-167.
203. Spugnini E.P., Citro G., Fais S. Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy. J. Exp. Clin. Cancer Res. 2010, 29:44.
204. Srivastava J., Barreiro G., Groscurth S., Gingras A.R., Goult B.T., Critchley D.R., Kelly M.J., Jacobson M.P., Barber D.L. Structural model and functional significance of pH-dependent talin-actin binding for focal adhesion remodeling. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14436-14441.
205. + exchangers and RhoA regulate acidic extracellular pH-induced lysosome trafficking in prostate cancer cells. Traffic 2009, 10:737-753.
206. + exchangers. J. Cell Sci. 2010, 123:1151-1159.
207. Steffen A., Le Dez G., Poincloux R., Recchi C., Nassoy P., Rottner K., Galli T., Chavrier P. MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7. Curr. Biol. 2008, 18:926-931.
208. Stewart A.K., Boyd C.A., Vaughan-Jones R.D. A novel role for carbonic anhydrase: cytoplasmic pH gradient dissipation in mouse small intestinal enterocytes. J. Physiol. 1999, 516(Pt 1):209-217.
209. Stock C., Cardone R.A., Busco G., Krahling H., Schwab A., Reshkin S.J. Protons extruded by NHE1: digestive or glue?. Eur. J. Cell Biol. 2008, 87:591-599.
210. Stock C., Ludwig F.T., Schwab A. Is the multifunctional na(+)/h(+) exchanger isoform 1 a potential therapeutic target in cancer?. Curr. Med. Chem. 2012, 19:647-660.
211. Stock C., Mueller M., Kraehling H., Mally S., Noel J., Eder C., Schwab A. pH nanoenvironment at the surface of single melanoma cells. Cell. Physiol. Biochem. 2007, 20:679-686.
212. Stock C., Schwab A. Protons make tumor cells move like clockwork. Pflugers Arch. 2009, 458:981-992.
213. Stock C., Schwab A. Role of the Na/H exchanger NHE1 in cell migration. Acta Physiol. (Oxf.) 2006, 187(1-2):149-157.
214. Stuwe L., Muller M., Fabian A., Waning J., Mally S., Noel J., Schwab A., Stock C. pH dependence of melanoma cell migration: protons extruded by NHE1 dominate protons of the bulk solution. J. Physiol. 2007, 585:351-360.
215. Sundquist K., Lakkakorpi P., Wallmark B., Vaananen K. Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption. Biochem. Biophys. Res. Commun. 1990, 168:309-313.
216. Supuran C.T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discov. 2008, 7:168-181.
217. Supuran C.T. Carbonic anhydrases - an overview. Curr. Pharm. Des. 2008, 14:603-614.
218. Tarone G., Cirillo D., Giancotti F.G., Comoglio P.M., Marchisio P.C. Rous sarcoma virus-transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane called podosomes. Exp. Cell Res. 1985, 159:141-157.
219. Tatin F., Varon C., Genot E., Moreau V. A signalling cascade involving PKC, Src and Cdc42 regulates podosome assembly in cultured endothelial cells in response to phorbol ester. J. Cell Sci. 2006, 119:769-781.
220. Teti A., Blair H.C., Teitelbaum S.L., Kahn A.J., Koziol C., Konsek J., Zambonin-Zallone A., Schlesinger P.H. Cytoplasmic pH regulation and chloride/bicarbonate exchange in avian osteoclasts. J. Clin. Invest. 1989, 83:227-233.
221. Teti A., Grano M., Carano A., Colucci S., Zambonin Zallone A. Immunolocalization of beta 3 subunit of integrins in osteoclast membrane. Boll. Soc. Ital. Biol. Sper. 1989, 65:1031-1037.
222. Thompson E.W., Paik S., Brunner N., Sommers C.L., Zugmaier G., Clarke R., Shima T.B., Torri J., Donahue S., Lippman M.E., et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell. Physiol. 1992, 150:534-544.
223. Tominaga T., Barber D.L. Na-H exchange acts downstream of RhoA to regulate integrin-induced cell adhesion and spreading. Mol. Biol. Cell 1998, 9:2287-2303.
224. +-ATPase with the a3 isoform during osteoclast differentiation. J. Biol. Chem. 2003, 278:22023-22030.
225. Toyomura T., Oka T., Yamaguchi C., Wada Y., Futai M. Three subunit a isoforms of mouse vacuolar H(+)-ATPase. Preferential expression of the a3 isoform during osteoclast differentiation. J. Biol. Chem. 2000, 275:8760-8765.
226. Tu C., Ortega-Cava C.F., Chen G., Fernandes N.D., Cavallo-Medved D., Sloane B.F., Band V., Band H. Lysosomal cathepsin B participates in the podosome-mediated extracellular matrix degradation and invasion via secreted lysosomes in v-Src fibroblasts. Cancer Res. 2008, 68:9147-9156.
227. Turk B., Dolenc I., Turk V., Bieth J.G. Kinetics of the pH-induced inactivation of human cathepsin L. Biochemistry 1993, 32:375-380.
228. Vaananen H.K., Karhukorpi E.K., Sundquist K., Wallmark B., Roininen I., Hentunen T., Tuukkanen J., Lakkakorpi P. Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts. J. Cell Biol. 1990, 111:1305-1311.
229. Vaananen H.K., Laitala-Leinonen T. Osteoclast lineage and function. Arch. Biochem. Biophys. 2008, 473:132-138.
230. Vaananen H.K., Zhao H., Mulari M., Halleen J.M. The cell biology of osteoclast function. J. Cell Sci. 2000, 113(Pt 3):377-381.
231. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
232. Vaughan-Jones R.D., Peercy B.E., Keener J.P., Spitzer K.W. Intrinsic H(+) ion mobility in the rabbit ventricular myocyte. J. Physiol. 2002, 541:139-158.
233. + exchange is necessary for RhoA-induced stress fiber formation. J. Biol. Chem. 1996, 271:22281-22284.
234. +-ATPase. Physiol. Rev. 2004, 84:1263-1314.
235. Weaver A.M. Invadopodia: specialized cell structures for cancer invasion. Clin. Exp. Metastasis 2006, 23:97-105.
236. Webb B.A., Chimenti M., Jacobson M.P., Barber D.L. Dysregulated pH: a perfect storm for cancer progression. Nat. Rev. Cancer 2011, 11:671-677.
237. Weber W.A., Ziegler S.I., Thodtmann R., Hanauske A.R., Schwaiger M. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J. Nucl. Med. 1999, 40:1771-1777.
238. Wiesner C., Faix J., Himmel M., Bentzien F., Linder S. KIF5B and KIF3A/KIF3B kinesins drive MT1-MMP surface exposure, CD44 shedding, and extracellular matrix degradation in primary macrophages. Blood 2010, 116:1559-1569.
239. Wolf K., Alexander S., Schacht V., Coussens L.M., von Andrian U.H., van Rheenen J., Deryugina E., Friedl P. Collagen-based cell migration models in vitro and in vivo. Semin. Cell Dev. Biol. 2009, 20:931-941.
240. + exchanger 1 and its clinicopathologic significance in hepatocellular carcinoma. Med. Oncol. 2010, 27:1109-1113.
241. Yuan F.L., Li X., Lu W.G., Li C.W., Li J.P., Wang Y. The vacuolar ATPase in bone cells: a potential therapeutic target in osteoporosis. Mol. Biol. Rep. 2010, 37:3561-3566.
242. Zambonin-Zallone A., Teti A., Carano A., Marchisio P.C. The distribution of podosomes in osteoclasts cultured on bone laminae: effect of retinol. J. Bone Miner. Res. 1988, 3:517-523.
243. Zhao H., Ettala O., Vaananen H.K. Intracellular membrane trafficking pathways in bone-resorbing osteoclasts revealed by cloning and subcellular localization studies of small GTP-binding rab proteins. Biochem. Biophys. Res. Commun. 2002, 293:1060-1065.
244. Zhao H., Patrick Ross F. Mechanisms of osteoclastic secretion. Ann. N. Y. Acad. Sci. 2007, 1116:238-244.
245. +-ATPase is involved in its targeting to ruffled membranes of osteoclasts. J. Bone Miner. Res. 2006, 21:714-721.